Icon PLCShs News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13:00	ICON Announces Appointment of Chief Operating Officer (Businesswire)
05.12.24	ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption (Businesswire)
13.11.24	ICON plc to Present at the Jefferies London Healthcare Conference (Businesswire)
23.10.24	ICON Reports Third Quarter 2024 Results (Businesswire)
27.09.24	ICON plc Schedules Third Quarter 2024 Earnings Conference Call (Businesswire)
12.09.24	ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape (Businesswire)
03.09.24	ICON plc to Present at the Baird 2024 Global Healthcare Conference (Businesswire)
14.08.24	ICON Announces Appointment of New Chief Financial Officer (Businesswire)
24.07.24	ICON Reports Second Quarter 2024 Results (Businesswire)
24.07.24	ICON announces results of Annual General Meeting and changes to the Board of Directors (Businesswire)
10.07.24	ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer (Businesswire)
01.07.24	ICON plc Schedules Second Quarter 2024 Earnings Conference Call (Businesswire)
04.06.24	ICON plc to Present at the Jefferies Global Healthcare Conference (Businesswire)
30.05.24	ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance (Businesswire)
20.05.24	ICON plc to hold Investor Day Meeting on May 30, 2024 (Businesswire)
09.05.24	ICON releases its ICON Cares 2023 Report (Businesswire)
30.04.24	ICON Announces Pricing of USD 2 Billion Notes (Businesswire)
24.04.24	ICON Reports First Quarter 2024 Results (Businesswire)
03.04.24	ICON Announces CFO Transition (Businesswire)
25.03.24	ICON plc Schedules First Quarter 2024 Earnings Conference Call (Businesswire)
26.02.24	ICON plc to Present at Upcoming Investor Conferences (Businesswire)
21.02.24	ICON Reports Fourth Quarter and Full Year 2023 Results (Businesswire)
30.01.24	ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call (Businesswire)
24.01.24	New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment (Businesswire)
09.01.24	ICON Plc Issues FY24 Guidance - Quick Facts (RTTNews)
09.01.24	ICON Issues Financial Guidance for Full Year 2024 (Businesswire)
08.01.24	Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON (Businesswire)
04.01.24	ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
18.12.23	ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 (Businesswire)
07.12.23	ICON Secures Upgraded Credit Rating from Moody’s Investors Service (Businesswire)
08.11.23	ICON plc to Present at Upcoming Investor Conferences (Businesswire)
25.10.23	ICON Reports Third Quarter 2023 Results (Businesswire)
12.10.23	ICON Secures Upgraded Credit Rating from S&P Global Ratings (Businesswire)
21.09.23	ICON plc Schedules Third Quarter 2023 Earnings Conference Call (Businesswire)
20.09.23	ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution (Businesswire)
13.09.23	BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial (Businesswire)
06.09.23	ICON plc to Present at the Baird Global Healthcare Conference (Businesswire)
26.07.23	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting (Businesswire)
26.07.23	ICON Reports Second Quarter 2023 Results (Businesswire)
13.07.23	First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services (Businesswire)
27.06.23	ICON plc Schedules Second Quarter 2023 Earnings Conference Call (Businesswire)
26.06.23	ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform (Businesswire)
26.06.23	ICON plc Set to Join Russell 3000® Index (Businesswire)
31.05.23	ICON plc to Attend Upcoming Investor Conferences (Businesswire)
16.05.23	ICON releases its 2022 ICON Cares ESG Report (Businesswire)
26.04.23	ICON Reports First Quarter 2023 Results (Businesswire)
29.03.23	ICON plc Schedules First Quarter 2023 Earnings Conference Call (Businesswire)
10.03.23	LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology (Businesswire)
27.02.23	ICON plc to Present at Upcoming Investor Conferences (Businesswire)
22.02.23	ICON Reports Fourth Quarter and Full Year 2022 Results (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Icon PLCShs

Aktien Top/Flop

Meistgelesene Nachrichten